AITRICS VitalCare vs CLEW Medical (2026)
Both predict deterioration in hospitalized adults with machine learning, and both market their FDA clearances beyond what the clearances cover. AITRICS VitalCare, from Seoul, predicts deterioration and sepsis on general wards from up to 19 routine EHR inputs, and publishes sensitivity, alarms per 100 patient days and lead time across two company led studies. Its 510(k) clears a rules based early warning dashboard, while the company claims clearance for its AI. CLEW Medical, from Israel with US operations in Boston, predicts deterioration in critical care for bedside and tele ICU teams, and its 510(k) summaries state its operating characteristics. The clearance covers adult critical care, and a 2024 company release put the cleared label on medical and surgical floors. Choose VitalCare for general wards; choose CLEW for the ICU, within its cleared indication.
- Your wards measure patients intermittently rather than continuously.
- You want sensitivity, alert burden and lead time published.
- Deterioration and sepsis should come from one model.
- Your use is adult critical care or tele ICU.
- You want operating characteristics stated in a 510(k) summary.
- Alarm burden published in a peer reviewed journal matters to your committee.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. AITRICS VitalCare and CLEW Medical are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | AITRICS VitalCare | CLEW Medical |
|---|---|---|
| Primary category | Inpatient Deterioration & Risk Monitoring | Inpatient Deterioration & Risk Monitoring |
| Headquarters | Seoul, Republic of Korea | Netanya, Israel |
| Website | aitrics.com | clewmed.com |
Side by Side
Select any grade to read the note behind it.
Each vendor in one paragraph
Written to be quoted whole. Each paragraph opens the AI Health Index profile of the vendor: what the product is, who buys it and what it does.
AITRICS is a Seoul medical AI company whose AITRICS-VC (VitalCare) predicts deterioration in hospitalized adults from routine electronic medical record data. It focuses on the general ward, where patients are measured intermittently rather than monitored continuously, so the models must work from sparse, irregular measurements.
Source: AI Health Index, September 2026
CLEW Medical, based in Netanya, Israel, with US operations in Boston, sells FDA cleared machine learning models that predict clinical deterioration in hospital critical care, delivered through a clinical surveillance platform for bedside and tele-ICU teams. Its operating characteristics are public because the models are regulated as medical devices and the 510(k) summaries state them.
Source: AI Health Index, September 2026
Questions buyers ask
How do AITRICS VitalCare and CLEW Medical work with the EHR?
For AITRICS VitalCare, the US 510(k) describes the software analyzing patient data sourced from the EHR, and the product page describes connecting to the hospital's internal network to collect EMR data.
With CLEW Medical, the 510(k) describes the server importing EHR and bedside monitor data over an HL7 connection, the sensible choice for device streams that FHIR serves poorly, and a heavier build than an app. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified September 29, 2026. No vendor pays for placement.
What evidence is published for AITRICS VitalCare and CLEW Medical?
In AITRICS VitalCare's case, a before-and-after study at Presbyterian Medical Center (JMIR Medical Informatics, 2025; 30,785 cases) reported 24.97 percent fewer Code Blue and major events after go-live. Jang and colleagues (Journal of Clinical Medicine, 2026; Yongin Severance) set an alarm-based threshold giving sensitivity of 0.52 at 9.67 alarms per 100 patient-days, against 0.23 and 0.17 for NEWS and MEWS.
CLEWHI reached 63 and 69 percent sensitivity, 93 and 87 percent specificity, and 12 and 10 percent positive predictive value; CLEWLR reached 47 and 35.5 percent sensitivity at about 90 percent specificity, all against targets set before testing. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified September 29, 2026. No vendor pays for placement.
How much do AITRICS VitalCare and CLEW Medical leave to the clinician?
With AITRICS VitalCare, the US clearance states the software is not intended to replace bedside monitors or clinicians' decisions and is indicated solely for the general ward, not the ICU or operating rooms, and the product page says it is for use by doctors and nurses. Scores and alarms go to clinicians with the grounds for each alarm shown; nothing is auto-actioned.
CLEWHI flags patients likely to need vasopressor or inotrope support within eight hours; CLEWLR labels patients as low risk of deterioration, a label a unit may lean on when deciding who can step down. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified September 29, 2026. No vendor pays for placement.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Inpatient Deterioration & Risk Monitoring page.
AITRICS's record was reviewed on this site in September 2026; CLEW's site could not be read at review, so parts of its record rest on earlier reads. Neither publishes a price, and both have described their clearance as covering more than it does.
Ask both to show the indication in their 510(k) letter, and which of your units it covers.